Litcius/Paper detail

1960O Identification of bladder cancer patients that could benefit from early post-cystectomy immunotherapy based on serial circulating tumour DNA (ctDNA) testing: Preliminary results from the TOMBOLA trial

Jørgen Bjerggaard Jensen, Karin Birkenkamp‐Demtröder, Iver Nordentoft, Rikke Vilsbøll Milling, Stefanie Korsgaard Körner, S.B. Brandt, Marie Veje Knudsen, Gitte Wrist Lam, Line Hammer Dohn, Knud Fabrin, Andreas Carus, Astrid Petersen, Ulla Nordström Joensen, Helle Pappot, P.S. Holt, Niels Viggo Jensen, Mads Agerbæk, Lars Dyrskjøt

2024Annals of Oncology28 citationsDOIOpen Access PDF

Topics & Concepts

MedicineCystectomyBladder cancerImmunotherapyOncologyCirculating tumor DNAInternal medicineCancerUrologyBladder and Urothelial Cancer TreatmentsCancer Immunotherapy and BiomarkersCancer Genomics and Diagnostics
1960O Identification of bladder cancer patients that could benefit from early post-cystectomy immunotherapy based on serial circulating tumour DNA (ctDNA) testing: Preliminary results from the TOMBOLA trial | Litcius